Cronin Group PLC Presentation at Healthcare Conference
January 31 2017 - 2:01AM
RNS Non-Regulatory
TIDMCRON
Cronin Group PLC
31 January 2017
31 January 2017
Cronin Group Plc
("Cronin" or the "Company")
Presentation at Healthcare Conference
Between the 9(th) and 12(th) January 2017 Professor Lee Cronin,
Founding Scientific Director, will be attending the 35th Annual
J.P. Morgan Healthcare Conference and at which he will be
presenting the Company's pathway to its first commercial
product.
During 2017 Cronin Group intends to release prototype and beta
versions of its DigitialGlassware(TM) product, which it anticipates
will undergo testing and development with a number of collaboration
partners. Early product releases of DigitalGlassware(TM) will be a
low-cost, easy to use chemical telemetry product designed to enable
the first digitization of chemistry in commercial and academic
research laboratories. Eventually the DigitalGlassware(TM) platform
is envisaged to have a range of commercial applications in various
target markets, including Healthcare.
Cronin Group's ultimate vision is to commercialise the
Chemputer(TM), an autonomous universal digital synthesis engine,
which intends to open up chemistry to a wider user-base via
digitization. This will allow chemical synthesis to be flexible and
widely accessible irrespective of access to physical infrastructure
and chemical knowledge.
ENDS
Contacts:
Cronin Group Plc www.croningroupplc.com
James Ede-Golightly, Chairman T: 01481 701 564
WH Ireland Limited www.wh-ireland.co.uk
Mike Coe / Ed Allsopp T: 0117 945 3470
This information is provided by RNS
The company news service from the London Stock Exchange
END
NRASDIFESFWSESF
(END) Dow Jones Newswires
January 31, 2017 02:01 ET (07:01 GMT)
Oxford Advanced Surfaces (LSE:OXA)
Historical Stock Chart
From Apr 2024 to May 2024
Oxford Advanced Surfaces (LSE:OXA)
Historical Stock Chart
From May 2023 to May 2024